BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19726402)

  • 21. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
    Battistini S; Giannini F; Greco G; Bibbò G; Ferrera L; Marini V; Causarano R; Casula M; Lando G; Patrosso MC; Caponnetto C; Origone P; Marocchi A; Del Corona A; Siciliano G; Carrera P; Mascia V; Giagheddu M; Carcassi C; Orrù S; Garrè C; Penco S
    J Neurol; 2005 Jul; 252(7):782-8. PubMed ID: 15789135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers.
    Vucic S; Winhammar JM; Rowe DB; Kiernan MC
    Clin Neurophysiol; 2010 Oct; 121(10):1781-5. PubMed ID: 20362497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
    Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
    Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation.
    Curti D; Rognoni F; Alimonti D; Malaspina A; Feletti F; Tessera S; Finotti N; Rehak L; Mazzini L; Zerbi F; Poloni TE; Ceroni M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):115-22. PubMed ID: 12495572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
    Debray S; Race V; Crabbé V; Herdewyn S; Matthijs G; Goris A; Dubois B; Thijs V; Robberecht W; Van Damme P
    Neurobiol Aging; 2013 Dec; 34(12):2890.e7-2890.e12. PubMed ID: 23870417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium.
    Aguirre T; Matthijs G; Robberecht W; Tilkin P; Cassiman JJ
    Eur J Hum Genet; 1999 Jul; 7(5):599-602. PubMed ID: 10439968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene.
    Cudkowicz ME; McKenna-Yasek D; Chen C; Hedley-Whyte ET; Brown RH
    Ann Neurol; 1998 Jun; 43(6):703-10. PubMed ID: 9629839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular approaches to amyotrophic lateral sclerosis.
    Smith RG; Appel SH
    Annu Rev Med; 1995; 46():133-45. PubMed ID: 7598450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases.
    van Rheenen W; van Blitterswijk M; Huisman MH; Vlam L; van Doormaal PT; Seelen M; Medic J; Dooijes D; de Visser M; van der Kooi AJ; Raaphorst J; Schelhaas HJ; van der Pol WL; Veldink JH; van den Berg LH
    Neurology; 2012 Aug; 79(9):878-82. PubMed ID: 22843265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.
    Kabashi E; Valdmanis PN; Dion P; Spiegelman D; McConkey BJ; Vande Velde C; Bouchard JP; Lacomblez L; Pochigaeva K; Salachas F; Pradat PF; Camu W; Meininger V; Dupre N; Rouleau GA
    Nat Genet; 2008 May; 40(5):572-4. PubMed ID: 18372902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?
    Gamez J; Corbera-Bellalta M; Nogales G; Raguer N; García-Arumí E; Badia-Canto M; Lladó-Carbó E; Alvarez-Sabín J
    J Neurol Sci; 2006 Aug; 247(1):21-8. PubMed ID: 16674979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis.
    Liu HN; Sanelli T; Horne P; Pioro EP; Strong MJ; Rogaeva E; Bilbao J; Zinman L; Robertson J
    Ann Neurol; 2009 Jul; 66(1):75-80. PubMed ID: 19670443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy.
    Conforti FL; Sprovieri T; Mazzei R; Ungaro C; La Bella V; Tessitore A; Patitucci A; Magariello A; Gabriele AL; Tedeschi G; Simone IL; Majorana G; Valentino P; Condino F; Bono F; Monsurrò MR; Muglia M; Quattrone A
    Neuromuscul Disord; 2008 Jan; 18(1):68-70. PubMed ID: 17703939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
    Ihara Y; Nobukuni K; Takata H; Hayabara T
    Neurol Res; 2005 Jan; 27(1):105-8. PubMed ID: 15829169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress.
    Aguirre T; Van Den Bosch L; Goetschalckx K; Tilkin P; Mathijs G; Cassiman JJ; Robberecht W
    Ann Neurol; 1998 Apr; 43(4):452-7. PubMed ID: 9546325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.